Last reviewed · How we verify
NCT04242797
Central Mechanisms of Calmare: an fMRI Trial
NA trial testing Calmare in Peripheral Neuropathy in 39 participants. Completed in 15 November 2017.
15 November 2017
Quick facts
| Lead sponsor | Brigham Young University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 39 |
| Start date | 1 August 2015 |
| Primary completion | 15 November 2017 |
| Estimated completion | 15 November 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Calmare
- TENS
Conditions studied
- Peripheral Neuropathy — all drugs for Peripheral Neuropathy →
Sponsor
Brigham Young University
Who can join
Adults 18 to 75, any sex, with Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pilot one-treatment and extended 10-treatment studies are carried out on participants with peripheral neuropathy comparing traditional TENS and Calmare stimulation protocols using a double-blind apparatus. Resting fMRI scans are obtained before and after the treatment, as well as after most of the pain has returned.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04242797
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Neuropathy
Currently open trials in the same condition.
- NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
- NCT07025005 — Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VR · Phase 4 · recruiting
- NCT07163000 — Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT) · active not recruiting
- NCT07055711 — Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT · active not recruiting
- NCT06615622 — Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic · recruiting
Other Brigham Young University trials
Trials by the same sponsor.
- NCT06053229 — Effect of Percussive Massage on Skeletal Muscle During Limb Immobilization · NA · recruiting
- NCT05902286 — Heart Rate Variability Biofeedback in Older Adults · EARLY_PHASE1 · completed
- NCT05913505 — Heart Rate Variability Biofeedback Following Traumatic Brain Injury · EARLY_PHASE1 · unknown
- NCT05044715 — Effectiveness of Compassion Focused Therapy (CFT) · NA · terminated
- NCT04733287 — Heat Therapy and Muscle Function Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04242797 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brigham Young University
- Last refreshed: 27 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04242797.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing